Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug  Bloomberg

A U.S. jury on Friday rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva Pharmaceutical Industries Ltd.